Cromolyn Sodium Inhalant
NDC Package 42571-350-50
Package Information
Cromolyn Sodium inhalants is a medication used to treat certain allergic eye conditions (vernal keratoconjunctivitis, vernal conjunctivitis, vernal keratitis). This formulation utilizes a inhalant delivery system. Marketed by Micro Labs Limited, this product is identified by NDC 42571-350 and is authorized under FDA application ANDA213658.
Identification & Billing
- RxCUI: 831246 - cromolyn sodium 20 MG in 2 ML Inhalation Solution
- RxCUI: 831246 - cromolyn sodium 10 MG/ML Inhalation Solution
- RxCUI: 831246 - cromolyn sodium 20 MG per 2 ML Inhalation Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 42571 - Micro Labs Limited
- 42571-350 - Cromolyn Sodium
- 42571-350-50 - 10 CARTON in 1 CARTON / 12 AMPULE in 1 CARTON / 2 mL in 1 AMPULE (42571-350-08)
- 42571-350 - Cromolyn Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (42571-350). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42571-350-50 identifies a specific commercial package of 10 carton in 1 carton / 12 ampule in 1 carton / 2 ml in 1 ampule (42571-350-08) of Cromolyn Sodium, a human prescription drug labeled by Micro Labs Limited. This inhalant is formulated for intrabronchial use and contains cromolyn sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Micro Labs Limited on June 01, 2022. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat certain allergic eye conditions (vernal keratoconjunctivitis, vernal conjunctivitis, vernal keratitis). It prevents itching of the eyes that can occur with these conditions. Cromolyn is known as a mast cell stabilizer. It works by blocking certain natural substances (histamine, SRS-A) that cause allergic symptoms.
How is this Micro Labs Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42571035050. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.